Blood Transfusion in Sickle Cell Disease

Vox Sanguinis

Volumn 68, Issue 3, 1995, Pages 145-151

  Davies, Sally C ^a   Olatunji, P O ^b  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ILORIN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOOD VISCOSITY; ERYTHROCYTE TRANSFUSION; HUMAN; INFECTION; IRON OVERLOAD; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; BLOOD VISCOSITY; ERYTHROCYTE TRANSFUSION; HUMAN; IRON; ISOANTIBODIES; OVERDOSE; VIRUS DISEASES;

EID: 0028951940     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1995.tb03916.x     Document Type: Review

References (44)

1. Mortality in children and adolescents with sickle cell disease
2. Mortality in sickle cell disease: Life expectancy and risk factors for early death
3. Bone marrow transplantation in sickle cell anemia
4. Blood transfusion in sickle cell disease
5. Red cell alloimmunization in sickle cell disease
6. Transfusion and alloimmunization in sickle cell disease
7. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood
8. Delayed haemolytic transfusion reactions in patients with sickle cell disease
9. Alloantibody responses in multiply transfused sickle cell patients
10. A simple, practical model for reducing alloimmunization in patients with sickle cell disease
11. Effects of transfusion on rheological properties of blood in sickle cell anemia
12. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels; implications for transfusion
13. Improved exercise performance after exchange transfusion in subjects with sickle cell anemia
14. Painful sickle cell crises precipitated by stopping prophylactic exchange transfusions
15. Neurologic events after partial exchange transfusion for priapism in sickle cell disease
16. Association of sickle cell disease, priapism, exchange transfusion and neurological events. Aspen syndrome
17. Hypertension, convulsions, and cerebral haemorrhage in sickle‐cell anaemia patients after blood transfusions
18. Binding of serum ferritin to concanavalin A: Patients with homozygous beta‐thalassaemia and transfusional iron overload
19. Iron chelation by deferoxamine in sickle cell patients with severe transfusion induced hemosiderosis: A randomized, double‐blind study of the dose‐response relationship
20. Zinc status of children with sickle cell disease: Relationship to poor growth
21. 1) in patients with iron overload
22. A modified transfusion program for prevention of stroke in sickle cell disease
23. Increased blood requirements during long‐term transfusion therapy for sickle cell disease
24. Splenic re‐growth in sickle cell disease following hyper‐transfusion
25. Acute chest syndrome in sickle cell disease
26. Mortality in sickle disease: The experience of a British centre
27. Stroke
28. Pseudomembranous colitis in sickle cell disease responding to exchange transfusion
29. Elective surgery in children with sickle cell disease without preoperative blood transfusion
30. Less intensive long‐term transfusion therapy for sickle cell anemia and cerebrovascular accident
31. The natural history of stroke in sickle cell disease
32. Stroke in a cohort study of patients with homozygous sickle cell disease
33. Stroke in sickle cell disease: Demographic, clinical, and therapeutic considerations
34. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents
35. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease
36. Sickle cell chronic lung disease: Prior morbidity and the risk of pulmonary failure
37. Prophylactic red‐cell transfusions in pregnant patients with sickle cell disease
38. Long‐term management of splenic sequestration in children with sickle cell disease
39. Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell disease
40. Increased incidence of hepatitis B markers in children with sickle cell anaemia
41. The pathology of sickle cell disease
42. Sickle cell disease in childhood
43. General anaesthesia in sickle cell disease